Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 63, Issue 5-6, 2000, Pages 215-221

  Basco, L K ^a   Ringwald, P ^a  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; DNA; FANSIDAR; HALOFANTRINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; PYRONARIDINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SMEAR; CAMEROON; CHILD; CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG EFFICACY; ENDEMIC DISEASE; GAMETOCYTE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MEROZOITE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; REINFECTION; SPOROZOITE;

ARTESUNATE; PROTOZOA;

EID: 0034437807     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.63.215     Document Type: Article

References (39)

1. Chemotherapy of malaria and resistance to antimalarials: Report of a WHO Scientific Group
2. Monitoring the response of malaria infections to treatment
3. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa
4. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children
5. Adaptations of the Sakar-Solomons test: Simple, reliable colorimetric field assays for chloroquine and its metabolites in urine
6. Severe and complicated malaria
7. Molecular epidemiology of malaria in Yaoundé Cameroon. I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum
8. Plasmodium falciparum: A simple polymerase chain reaction method for differentiating strains
9. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum
10. Plasmodium falciparum: Gene structure and by dropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate
11. Structural diversity in the Plasmodium falciparum merozoite surface antigen 2
12. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique
13. Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates
14. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment
15. Human malaria parasites in continuous culture
16. Drug sensitivity tests in malaria parasites
17. Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaoundé, Cameroon
18. Plasmodium falciparum: Drug sensitivity in vitro of isolates before and after adaptation to continuous culture
19. Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum
20. Plasmodium falciparum: Recrudescence of parasites in culture
21. A primary malarial infection is composed of a very wide range of genetically diverse but related parasites
22. A study of the genomic diversity of Plasmodium falciparum in Senegal. 2. Typing by the use of the polymerase chain reaction
23. Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites
24. Single-strand conformational polymorphism analysis differentiates Plasmodium falciparum treatment failures from re-infections
25. Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites
26. Sequence diversity and molecular evolution of the merozoite surface antigen 2 of Plasmodium falciparum
27. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon
28. Amodiaquine as the first-line treatment of malaria in Yaoundé, Cameroon: Presumptive evidence from activity in vitro and cross-resistance patterns
29. In vitro activity of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum
30. Chimiorésistance de P. falciparum en milieu urbain à Yaoundé, Cameroon. Part 2: Evaluation de l'efficacité de l'amodiaquine et de l'association sulfadoxine-pyriméthamine pour le traitement de l'accès palustre simple à Plasmodium falciparum à Yaoundé
31. Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon
32. Halofantrine: A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential
33. Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients
34. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria
35. Monotherapy with sodium artesunate for uncomplicated malaria in Thailand: A comparison of 5- and 7-day regimens
36. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand
37. Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56697 and chloroquine in Tanzanian children